Skip to content

Updates: Products

aProximateâ„¢ Assay-Ready Plates launch poster.
18th January, 2023

New Product Launched – aProximate™ 96-well Assay-Ready Plates

Get our aProximateâ„¢ PTCs to your lab anywhere in the world (24 & 96-well plates) aProximateâ„¢ Assay-ready plates contain freshly isolated primary human proximal tubule cells (PTCs). The plates are…

Read update
A massively zoomed in image for the slider
12th October, 2022

First podocyte toxicity assay now commercially available

Damage to the glomerular filtration barrier (GFB) results in protein leakage from the plasma into the urine, so called proteinuria, and is associated with loss of kidney function, which…

Read update
Glomerulus
11th August, 2022

How a glomerulus in vitro model can accelerate drug development

The glomerulus is the part of the kidney involved in the filtration of solutes and waste from the blood. Damage to the glomerulus by diabetes mellitus, hypertension, glomerulonephritis, or…

Read update
24 Plate Product
13th July, 2022

New Product Launched – aProximate™ Assay-Ready Plates for transporter studies

aProximateâ„¢ Assay-ready plates contain freshly isolated primary human proximal tubule cells (PTCs). The plates are provided in an easy to use 24-well Transwell® format. Visit our product page…

Read update
Retinal organoids
28th April, 2022

Retinal Organoids for Drug Discovery

Retinal diseases have been at the forefront of gene and cell therapy over the last 30 years with conditions such as macular degeneration and Stargardt disease likely to be…

Read update
Newcells Biotech
5th November, 2021

iPSC-derived Retinal Organoids: an alternative in vitro model for drug discovery

What retinal models are available for drug development? Animal models are the most frequently used for investigating safety and efficacy of ophthalmic drugs. However, due to several key physiological differences,…

Read update
iPSC-derived retinal pigment epithelial (RPE) cells
28th April, 2023

Latest innovation in retina models brings a fully characterised Retina Pigment Epithelium (RPE)

Why develop an RPE model? Retinal pigment epithelium (RPE) cells play a vital role in the retina by forming the outer blood-retinal barrier and maintaining photoreceptor and visual…

Read update
ADC, Antibody drug conjugate,
20th April, 2023

Antibody drug conjugates (ADCs) – the role of in vitro models in safety assessment

One the fastest growing approaches to treat cancer is the use of antibody drug conjugates (ADCs). Since the approval of the first antibody drug conjugate  in 2000,…

Read update
13th April, 2023

The inside story of the development of Newcells’ MPS flow model: Scientific chat with Dr Colin Brown

When did you start thinking about incorporating flow into static kidney models? I have been working with static kidney models for over 30 years and started to think about…

Read update
Newcells Biotech
21st March, 2023

Newcells Biotech collaborates with consortium in Eurostars funded project to advance novel therapy for Alpha-1 Antitrypsin (AAT) Deficiency

The Eurostars grant of €1.2m will support the partners, led by Gain, and includes Newcells, the Institute for Research in Biomedicine (Lausanne) and the University of Helsinki.  Newcells will…

Read update
fibroblast and collagen
27th February, 2023

The latest FMT Assay: An invaluable tool for modelling fibrotic disease

Fibrotic diseases, including liver fibrosis, pulmonary fibrosis, and renal fibrosis, are characterized by the excessive deposition of extracellular matrix (ECM) components, leading to the formation of fibrous tissue that…

Read update
Image of a women
9th February, 2023

Latest trends in Retinal Organoids: Scientific chat with Dr Valeria Chichagova

What is the main advantage of having microglia in the neural retina model? First of all, incorporating microglial cells improves physiological relevance of the current iPSC-derived retinal organoid model…

Read update

Get our latest updates straight to your inbox